Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Historical Holders from Q1 2023 to Q3 2025

Symbol
MRKR on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
16,869,505
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,426,371
Holdings value
$3,060,094
% of all portfolios
0%
Number of holders
31
Number of buys
15
Number of sells
-10
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
New Enterprise Associates 16, L.P. 9.9% -21% $1,703,483 +$45,291 1,670,081 +2.7% New Enterprise Associates 16, L.P. 13 Nov 2025
Alyeska Investment Group, L.P. 9.9% -0.9% $1,143,378 +$188,600 1,280,952 +20% Alyeska Investment Group, L.P. 30 Sep 2025
Blue Owl Capital Holdings LP 9.99% +96% $1,431,356 +$727,459 1,127,052 +103% Blue Owl Capital Holdings LP 31 Mar 2025

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 3,426,371 $3,060,094 -$186,918 $0.8926 31
2025 Q2 3,410,487 $5,218,067 -$775,167 $1.53 31
2025 Q1 4,023,536 $4,948,972 +$278,481 $1.23 31
2024 Q4 3,484,395 $10,763,745 +$4,748,926 $3.11 31
2024 Q3 1,936,917 $5,462,150 -$201,922 $2.82 27
2024 Q2 1,938,345 $10,524,473 +$162,842 $5.43 26
2024 Q1 1,911,504 $8,219,717 +$19,050 $4.3 26
2023 Q4 1,906,940 $10,488,483 +$197,065 $5.5 24
2023 Q3 1,871,217 $8,502,131 +$261,000 $4.54 26
2023 Q2 1,824,779 $5,655,903 +$1,085,797 $3.1 27
2023 Q1 1,624,962 $1,154,593 +$1,154,593 $0.71 26